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Abstract 
Healing  of  fractures  is  different  for  each
bone and bone turnover markers may reflect
the fracture healing process. The purpose of
this study was to determine the characteristic
changes in bone turnover markers during the
fracture  healing  process.  The  subjects  were
consecutive  patients  with  femoral  neck  or
trochanteric fracture who underwent surgery
and achieved bone union. There were a total of
39 patients, including 33 women and 6 men.
There were 18 patients (16 women and 2 men)
with femoral neck fracture and 21 patients (17
women and 4 men) with trochanteric fracture.
Serum  bone-specific  alkaline  phosphatase
(BAP)  was  measured  as  a  bone  formation
marker. Urine and serum levels of N-terminal
telopeptide of type I collagen (NTX), as well as
urine levels of C-terminal telopeptide of type I
collagen (CTX) and deoxypyridinoline (DPD),
were measured as markers of bone resorption.
All  bone  turnover  markers  showed  similar
changes in patients with either type of frac-
ture,  but  significantly  higher  levels  of  both
bone formation and resorption markers were
observed in trochanteric fracture patients than
in neck fracture patients. BAP showed similar
levels  at  one  week  after  surgery  and  then
increased.  Bone  resorption  markers  were
increased after surgery in patients with either
fracture. The markers reached their peak val-
ues at three weeks (BAP and urinary NTX),
five  weeks  (serum  NTX  and  DPD),  and  2-3
weeks  (CTX)  after  surgery.  The  increase  in
bone turnover markers after hip fracture sur-
gery and the subsequent decrease may reflect
increased bone formation and remodeling dur-
ing the healing process. Both fractures had a
similar bone turnover marker profile, but the
extent  of  the  changes  differed  between
femoral neck and trochanteric fractures. 
Introduction 
There has been considerable interest in the
assessment of bone turnover using biochemi-
cal markers, and measurement of various bone
turnover markers has recently become easier
for clinical use. Serum bone-specific alkaline
phosphatase (BAP) has been used for the eval-
uation of bone formation, while the breakdown
products of type I collagen have been reported
to  be  specific  and  sensitive  bone  resorption
markers.
1 It is now possible to use these mark-
ers to evaluate bone turnover in patients with
osteoporosis and other bone diseases.
2
Recently,  we  reported  that  bone  turnover
markers were significantly increased in elder-
ly women with back pain.
3 Vogt et al. reported
that only one-third of patients with vertebral
fractures knew of their existence.
4 In patients
with  osteoporosis,  vertebral  fractures  fre-
quently cause back pain
.5-7 Therefore, evalua-
tion of bone turnover using biochemical mark-
ers in elderly women may allow us to detect the
influence of unrecognized fractures.
3 Although
longitudinal changes in bone turnover mark-
ers after fracture have been reported and it has
been pointed out that these markers increase
during fracture healing,
8-17 there have been few
investigations  into  the  changes  in  bone
turnover  markers  in  patients  with  fragility
fractures. Generally, it is considered that the
process of fracture healing (amount of callus
formed, time until bone union, etc.) is differ-
ent for each fracture site. However, only a few
studies have compared the changes in bone
turnover  markers  between  different  fragility
fractures. Also, although the bone resorption
markers  available  for  clinical  testing  have
increased, there have been no reports on the
responses of various bone resorption markers
during the healing of fragility fractures.
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Figure 1. Time course of the serum levels of bone-specific alkaline phosphatase (BAP) in
femoral neck fracture patients and trochanteric fracture patients. [Orthopedic Reviews 2009; 1:e21] [page 51]
Hip fractures are the most common type of
fragility fracture and can cause many serious
or  even  fatal  complications  in  elderly
patients.
18,19 Hip fractures can be divided into
trochanteric and femoral neck fractures. These
two types of fracture occur in adjacent parts of
the proximal femur, but have quite different
clinical  features.  It  is  well  known  that  non-
union  is  common  in  patients  with  femoral
neck fractures, while it is rare in those with
trochanteric  fractures.  We  considered  that
these two types of hip fracture might be a use-
ful  model  for  assessing  differences  in  the
responses  of  bone  turnover  markers  after
fragility fracture. Recently, some authors have
reported  on  the  changes  in  bone  turnover
markers after femoral neck and trochanteric
fractures.
9,12,13 However,  there  have  been  no
reports  comparing  changes  in  bone-specific
turnover  markers  during  the  healing  of
femoral neck and trochanteric fractures. 
At Suwa Red Cross Hospital, multiple pins
are used to stabilize femoral neck fractures in
most patients, even when the fracture is dis-
placed. In the present prospective study, vari-
ous  bone  turnover  markers  were  measured
after surgery for femoral neck and trochanteric
fractures,  with  the  purpose  of  determining
whether there were characteristic short-term
changes in these markers during the healing
of proximal femoral fractures. 
Design and Methods 
The patients in this prospective study were
consecutive  patients  with  femoral  neck  or
trochanteric fracture who underwent surgical
intervention and achieved bone union at Suwa
Red  Cross  Hospital  between  January  and
December 2003. We performed universal hip
replacement (UHR) in patients with femoral
neck  fractures  who  were  in  a  poor  physical
and/or mental state. We also performed UHR in
patients with subcapital fractures and exclud-
ed them from this study. Patients who were
bedridden both before and after surgery due to
physical  and/or  mental  problems  were  also
excluded. 
A  total  of  39  patients  (33  women  and  6
men)  were  followed  up  after  surgery  and
achieved bone union. They formed the partic-
ipants in this study. Their age range was 56-96
years, with an average age of 78.3 years. There
were 18 patients (16 women and 2 men) with
femoral  neck  fractures  and  21  patients  (17
women  and  4  men)  with  trochanteric  frac-
tures. The average age of the former group
was 75.8 years and that of the latter group was
80.8 years (Table 1). All of the patients with
femoral  neck  fractures  were  treated  using
multiple  pins,  while  the  patients  with
trochanteric  fractures  were  treated  using
compression hip screws (CHS). 
Patients  with  both  types  of  fracture  were
permitted movement in a wheelchair as soon
as  possible  after  surgery.  Patients  with
trochanteric fracture were usually allowed to
start weight bearing from two weeks after sur-
gery,  while  patients  with  femoral  neck  frac-
tures usually commenced weight bearing from
four weeks and were encouraged to gradually
increase this. Bisphosphonate therapy was not
initiated until eight weeks after surgery. At six
months  after  surgery,  all  patients  were
assessed for clinical and radiological evidence
of  fracture  healing.  When  radiological  evi-
dence  of  bridging  callus,  sclerosis,  and/or
remodeling at the fracture site was confirmed
by two independent orthopedic surgeons and
the  patient  could  walk  without  pain  we
assumed that bone union was complete. 
Serum BAP was measured as a bone forma-
tion marker. Urine and serum levels of N-ter-
minal  telopeptide  of  type  I  collagen  (NTX),
urine levels of C-terminal telopeptide of type I
collagen  (CTX),  and  urine  levels  of
deoxypyridinoline  (DPD)  were  measured  as
markers of bone resorption. The levels of NTX
(Osteomark,  Osteox  International,  Seattle,
WA),  DPD  (Metrar  DPD  EIA  Kit,  Quidel
Corporation, San Diego, CA, USA), and CTX
(Frelisa‚  CrossLaps,  Nordic  Bioscience
Diagnostics,  A/S,  Herlev,  Denmark)  were
measured  using  the  enzyme-linked
immunosorbent  assay  (ELISA).  At  the  first
examination,  intact  parathyroid  hormone  (i-
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Table 1. Profile of the two fracture groups.
N. of  Male Female Age Intact PTH 25(OH)VitD3 
patients (range) (pg/mL) (ng/mL)
Femoral Neck 18 2 16 75.6±8.5 40.4±24.2 21.1±7.0
(56-94)
Trochanteric 21 4 17 80.8±7.7 41.5±15.6 19.8±7.5
(60-96)
p value 0.0589 0.882 0.605
Student’s t-test.
Table 2. Changes in the bone turnover markers.
Before 1 W 2 W 3 W 5 W 8 W
(U/L)Neck Neck 28.8±12.3 27.0±8.3 37.2±12.4 41.9±17.2 35.0±10.9 29.5±8.1
(8) (18) (18) (18) (15) (15)
Troch. 34.4±10.8 28.1± 7.3 53.4± 20.9 60.0± 28.4 49.3± 21.1 45.7± 21.5
(13) (21) (21) (21) (19) (16)
U-NTX Neck 93.3± 34.4 112.0± 63.4 117.2± 68.6 146.8± 78.9 139.7± 69.7 125.1± 47.2
(nmolBCE (8) (18) (18) (18) (18) (14)
/mmol·CRE)
Troch. 129.4± 76.5 166.5± 111.9 173.8± 91.6 215.3± 93.5 186.5± 94.3 185.4± 69.2
(13) (21) (21) (21) (21) (16)
S-NTX Neck 21.0± 8.2 26.4± 11.3 25.7± 13.9 29.4± 14.5 30.0± 14.6 27.4± 9.7
(nmolBCE/l) (6) (16) (16) (16) (16) (13)
Troch. 24.2± 6.6 26.6± 9.6 30.6± 9.9 38.3± 11.8 38.9± 10.5 35.7± 7.9
(11) (19) (19) (19) (16) (14)
DPD Neck 6.9± 2.6 9.4± 4.8 10.3± 4.1 11.4± 4.0 12.3± 5.2 11.4± 2.3
(nmol/mmol (6) (16) (16) (16) (16) (13)
·CRE)
Troch. 10.8± 4.8 13.1± 5.3 15.7± 6.8 18.5± 8.3 21.7± 10.9 18.7± 6.7
(12) (20) (20) (20) (17) (14)
CTX Neck 438± 126 532± 245 563± 286 640± 317 629± 262 561± 113
(μg/mmol (6) (16) (16) (16) (16) (13)
·CRE)
Troch. 630± 414 713± 372 933± 473 909± 420 807± 383 712± 202
(12) (20) (20) (20) (17) (15)
Neck: Femoral neck fracture, Troch.: Trochanteric fracture. *p < 0.05. (n = Number of patients)
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PTH) was measured in an immunoradiome-
toric assay and 25(OH) vitamin D (VitD) was
measured in a competitive radioimmunoassay
(except one case of trochanteric fracture). 
In principle, samples of venous blood and
spot urine were collected on the following six
occasions:  within  24  hours  after  injury,  and
one, two, three, five, and eight weeks after sur-
gery. Because pre-operative data were limited,
these data were excluded from the object of the
examination, and showed as a reference data.
The spot urine samples were collected from the
second morning urine, avoiding the first morn-
ing urine. Samples were stored at -20°C until
analysis.  Immunoassays  were  performed  by
SRL Inc. (Tokyo, Japan). 
All  patients  gave  informed  consent  to
undergo examination and medical treatment.
This study was carried out prospectively and
in accordance with the Helsinki Declaration,
and  approved  by  the  ethics  committees  of
Suwa Red Cross Hospital. Differences in the
age and the bone turnover markers at each
examination  between  patients  with  femoral
neck and trochanteric fractures were assessed
using Student’s unpaired t-test. Statistical sig-
nificance was set at a probability value of less
than 0.05. 
Results 
Patients'  background  data  are  shown  in
Table 1. The values of i-PTH and VitD showed
no  significant  differences  between  the  two
types of fracture. A correlation between i-PTH
and VitD was observed, but it was not signifi-
cant (p=0.053). All of the bone turnover mark-
ers were increased after surgery in patients
with either type of fracture, but there were sig-
nificantly higher values of both bone formation
and resorption markers in the patients with
trochanteric  fractures  than  in  those  with
femoral  neck  fractures  (Table  2).  All  of  the
bone turnover markers showed a similar pat-
tern of changes in both fractures, but the actu-
al values in bone turnover markers was small-
er in patients with femoral neck fracture than
in those with trochanteric fracture. 
BAP  (Figure  1)  showed  similar  levels  in
both fractures at one week after surgery and
then increased to reach 41.9±17.2 in femoral
neck  fracture  patients  and  60.0±28.4  U/L  in
trochanteric fracture patients at three weeks
after  surgery.  BAP  levels  were  significantly
higher in trochanteric fracture patients than
in neck fracture patients from two weeks after
surgery. In femoral neck fracture patients, BAP
decreased  to  29.5  U/L  after  eight  weeks.  In
trochanteric  fracture  patients,  however,  BAP
was 45.7±21.5 U/L at eight weeks and was still
high  compared  with  that  in  patients  with
femoral neck fractures. 
Urinary NTX (Figure 2) was increased after
surgery and showed a similar pattern in both
fractures, but urinary NTX levels were signifi-
cantly higher in trochanteric than neck frac-
ture  patients  from  two  weeks  after  surgery,
except at five weeks. At three weeks after sur-
gery, urinary NTX increased to 146.8±78.9 in
femoral  neck  fracture  patients  and  to
215.3±93.5  from  129.4±76.5  nmolBCE/
nmol·CRE  in  trochanteric  fracture  patients.
Urinary NTX reached its peak at three weeks
after  surgery  and  remained  high  compared
with the reference values until eight weeks in
both types of fracture. Serum NTX (Figure 3)
showed  similar  levels  in  trochanteric  and
femoral  neck  fracture  patients  at  one  week
after surgery, unlike urinary NTX and the other
bone resorption markers. Also unlike urinary
NTX, serum NTX increased later and reached a
peak  at  five  weeks  after  surgery,  remaining
high  at  eight  weeks.  Serum  NTX  reached
30.6±9.9 in femoral neck fracture patients and
38.9±10.5 nmolBCE/l in trochanteric fracture
patients.  Serum  NTX  was  only  significantly
higher in trochanteric fracture patients than
in femoral neck fracture at eight weeks after
surgery. Urinary and serum NTX revealed dif-
ferent patterns of change over time. 
Urinary DPD (Figure 4) increased after sur-
gery  and  showed  the  same  pattern  in  both
Article
Figure 3. Time course of the serum levels of NTX in femoral neck fracture patients and
trochanteric fracture patients. 
Figure 2. Time course of the urine levels of N-terminal telopeptide of type I collagen
(NTX) in femoral neck fracture patients and trochanteric fracture patients. [Orthopedic Reviews 2009; 1:e21] [page 53]
types of fracture, but DPD levels were signifi-
cantly greater in trochanteric than in femoral
neck fracture patients from one to eight weeks
after surgery. DPD increased to reach 12.3±5.2
in  femoral  neck  fracture  patients  and
21.7±10.9  nmol/mmol·CRE  in  trochanteric
fracture patients at five weeks after surgery. 
Urinary CTX (Figure 5) increased after sur-
gery  and  showed  the  same  pattern  in  both
types of fracture, but CTX levels were signifi-
cantly greater in trochanteric fracture patients
than  in  femoral  neck  fracture  patients  from
two weeks after surgery. Urinary CTX reached
933±473 at two weeks in trochanteric fracture
patients  and  640±317  at  three  weeks  in
femoral neck fracture patients, after which it
decreased. 
At  six  months  after  surgery,  all  of  the
patients achieved bone union of each fracture
site.  Despite  an  initial  diagnosis  of  bone
union,  re-evaluation  of  one  patient  with
femoral neck fracture led to a subsequent diag-
nosis of pseudarthrosis of femoral neck after
13 months post surgery, and UHR was subse-
quently  performed.  Another  patient  with
femoral neck fracture resulted in osteonecro-
sis of femoral head despite having achieved
bone union of the femoral neck. No patients
presented  surgical  site  infection  during  the
observation period. 
Discussion 
Bone turnover markers may reflect the frac-
ture  healing  process.  The  changes  in  bone
turnover markers during fracture healing are
believed to be greater than those that occur
during  the  physiological  remodeling  cycle.
Many authors have reported that bone turnover
markers are increased after fracture.
8-17
Femoral  neck  and  trochanteric  fractures
occur in adjacent parts of the proximal femur
in elderly people, but have quite different clin-
ical features. Therefore, we selected these two
hip  fractures  to  investigate  the  changes  in
bone  turnover  markers  after  bone  fragility
fracture  in  this  prospective  study.  We  found
that each bone turnover marker had the same
pattern of changes in the two different types of
hip fracture. On the other hand, both bone for-
mation and resorption markers showed signif-
icantly  higher  values  in  patients  with
trochanteric  fracture  than  in  those  with
femoral neck fracture. 
Generally,  it  is  considered  that  fracture
might directly influence bone formation and
that  immobilization  following  fracture  may
induce an increase in bone resorption. Bone
resorption  markers  are  strongly  related  to
physical  activity.
20-23 Theiler  et  al. found  that
bone  resorption  markers  were  significantly
higher in institutionalized and physically inac-
tive patients compared with those who were
ambulatory  and  physically  active.
22 Other
authors  have  reported  that  bone  resorption
markers  are  increased  by  bed  rest,
20-23 while
bone  formation  markers  decrease  with  bed
rest.
20 Decreased physical activity usually leads
to an increase in bone resorption and the inhi-
bition of bone formation. 
The patients with trochanteric fracture in
this study were older than those with femoral
neck fracture, as in previous reports.
16 It was
reported that in elderly women with osteoporo-
sis, urinary NTX levels increased with aging
but BAP levels did not change.
3 However, the
effect of aging on bone resorption markers is
slight.
3In this study, patients with both types of
fracture were permitted movement in a wheel-
chair as soon as possible after surgery, and
patients  with  femoral  neck  fracture  delayed
weight  bearing  for  longer  than  those  with
trochanteric fracture. In elderly patients, phys-
ical  activity  is  usually  decreased.  And  many
elderly patients often have difficulty walking
without  weight  bearing.  The  differences  in
physical activity, age, and post-operative thera-
py had various conflicting influences on bone
resorption markers in this study. 
With respect to post-operative therapy, phys-
ical  activity  might  be  slightly  greater  in
trochanteric  fracture  patients  than  in  those
with  femoral  neck  fracture.  Bone  resorption
markers  were  significantly  higher  in  the
Article
Figure 4. Time course of the urine levels of deoxypyridinoline (DPD) in femoral neck
fracture patients and trochanteric fracture patients. 
Figure 5. Time course of the urine levels of C-terminal telopeptide of type I collagen
(CTX) in femoral neck fracture patients and trochanteric fracture patients. [page 54] [Orthopedic Reviews 2009; 1:e21]
trochanteric fracture group than in the femoral
neck fracture group despite the difference in
physical  activity  and  post-operative  manage-
ment. Thus, the decrease in physical activity
due to post-operative therapy did not influence
the changes in bone resorption markers after
proximal  hip  fracture.  Accordingly,  the
changes  in  bone  resorption  markers  due  to
fracture healing might exceed those related to
physical  activity  in  elderly  patients  with  hip
fracture. 
In  general,  it  is  believed  that  appropriate
weight bearing helps bone union and it may
increase  bone  formation.  Therefore,  it  was
hypothesized that the increase in bone forma-
tion  markers  might  occur  earlier  with  early
weight bearing. In this study, all bone turnover
markers showed the same pattern of change in
both types of fracture although the time when
weight bearing was initiated differed between
the two patient groups. The difference in initi-
ation of weight bearing did not affect the pat-
tern of change in bone formation marker lev-
els. However, bone formation marker levels in
trochanteric  fracture  patients  were  signifi-
cantly greater than those in femoral neck frac-
ture patients.
In  this  study,  multiple  pinning  methods
were used for femoral neck fractures, and CHS
was  performed  for  trochanteric  fractures.
Multiple  pinning  surgery  was  performed  as
open surgery, like CHS. However, the surgical
invasiveness  of  CHS  is  greater  than  that  of
multiple pinning methods. Evaluation of the
effects of surgery based on C-reactive protein
and cytokine levels was limited to a short peri-
od.
24,25 Therefore, if the degree of surgical inva-
siveness  affects  bone  turnover  markers,  the
changes in bone turnover due to different sur-
gical procedures might be limited to a short
period. 
Previously,  Hosking  had  reported  that  the
increase  in  total  alkaline  phosphatase  was
similar during the healing of femoral neck and
trochanteric  fractures.
8 However,  Nakagawa
has recently reported that post-operative total
alkaline phosphatase levels were significantly
higher in trochanteric fracture patients than
in those with femoral neck fracture during the
healing process.
16 It has been reported that the
fracture of small bones (such as the wrist and
ankle) does not cause marked changes in bone
turnover  markers.
10,11 The  relative  extent  of
bone  formation  and  remodeling  during  the
fracture healing process would determine the
changes in bone turnover markers. In patients
with trochanteric fracture, radiographs show
that callus formation and/or remodeling during
the  healing  process  is  more  extensive  and
dynamic than in those with femoral neck frac-
ture (Figure 6) and these differences would be
reflected in the levels of bone formation mark-
ers. Furthermore, the difference in the area of
fracture might affect bone turnover markers.
In the present study, bone turnover marker lev-
els (including BAP) were significantly higher
in patients with trochanteric fracture than in
those with femoral neck fracture. The changes
in bone turnover markers corresponded to the
radiographic findings in femoral neck fracture,
and  the  results  of  this  study  supported
Nakagawa’s data but not those of Hosking. 
In this study, we also found that urinary and
serum NTX levels had a different pattern of
change. Recently, Akesson et al. have used a
fracture  model  to  assess  changes  in  bone
turnover  markers,  and  they  reported  that
serum  and  urinary  osteocalcin  (Oc)  levels
showed different changes after fracture
,15 i.e.
urinary Oc increased at 6-9 weeks but serum
Oc increased at 4-7 months after surgery. From
the results reported by Akesson et al. and the
findings  of  our  study,  some  bone  turnover
markers might show different changes in the
urine and serum during fracture healing. 
Based on the results of the current study,
bone  fragility  fractures  might  directly  affect
both  bone  formation  and  resorption  marker
levels. The changes in bone turnover markers
after fragility fracture at different sites might
have a similar pattern but differ with respect to
the extent of change.
In  this  study,  pre-operative  data  were  not
obtained  in  some  patients.  Therefore,  the
Article
Figure 6. The difference in callus formation between trochanteric fracture and femoral
neck  fracture  during  each  healing  process  in  radiographs.  In  trochanteric  fracture,
increased radiodensity along the fracture line, which is regarded as callus formation, is
observed at three months after surgery (shown by arrows). By contrast, the finding is
inconspicuous in femoral neck fracture (shown by an arrow). 
Trochanteric fracture 
just after surgery
Femoral neck fracture 
just after surgery  
Femoral neck fracture
three months after surgery
Trochanteric fracture 
three months after surgery[Orthopedic Reviews 2009; 1:e21] [page 55]
value of pre-operative data analysis would be
limited.  However,  post-operative  data  were
obtained from almost all patients and thus can
be considered reliable. 
In conclusion, an increase in bone turnover
markers after surgery for hip fracture and the
subsequent decrease may reflect bone forma-
tion and remodeling during the fracture heal-
ing process. We identified significant differ-
ences in bone formation and resorption mark-
er  levels  between  patients  with  trochanteric
and femoral neck fractures, even though these
both occur at adjacent sites in the proximal
femur. Our findings may reflect differences in
the amount of callus formation and/or remod-
eling  during  the  healing  of  these  fractures.
After  fragility  fracture  at  different  sites,  the
changes in bone turnover markers may show a
similar pattern, but differ in extent. 
References 
1. Hanson DA, Weis MA, Bollen AM, et al. A
specific  immunoassay  for  monitoring
human  bone  resorption:  quantitation  of
type 1 collagen cross-linked N-telopeptides
in urine. J Bone Miner Res 1997;7:1251-8. 
2. Nishizawa Y, Nakamura T, Ohta H, et al.
Guidelines  for  the  use  of  biochemical
markers of bone turnover in osteoporosis.
J Bone Miner Metab 2005;23:97-104.
3. Kamimura M, Uchiyama S, Takahara K, et
al.  Urinary  excretion  of  type  I  collagen
cross-linked  N-telopeptide  and  serum
bone-specific  alkaline  phosphatase:  Age
and back pain related changes in elderly
women. J Bone Miner Metab 2005;23:495-
500. 
4. Vogt  TM,  Ross  PD,  Palermo  L,  et  al.
Vertebral  fracture  prevalence  among
women  screened  for  the  Fracture  Inter-
vention Trial and a simple clinical tool to
screen  for  undiagnosed  vertebral  frac-
tures.  Fracture  Intervention  Trial
Research  Group.  Mayo  Clin  Proc
2000;75:888-96. 
5. Fnisen  V.  Osteoporosis  and  back  pain
among the elderly. Acta Med Scand 1988;
223:443-9. 
6.Cook GJ, Hannaford E, See M, et al. The
value of bone scintigraphy in the evalua-
tion  of  osteoporotic  patients  with  back
pain. Scand J Reumatol 2002;31:245-8. 
7.Takahara K, Kamimura M, Nakagawa H, et
al.  Radiographic  evaluation  of  vertebral
fractures in Osteoporotic Patients. J Clinic
Neurosc 2007;14:122-6. 
8.Hosking  DJ.  Changes  in  serum  alkaline
phosphatase  after  femoral  fractures.  J
Bone Joint Surg 1978;60-B:61-5. 
9.Ohishi T, Takahashi M, Kushida K, et al.
Changes  of  biochemical  markers  during
fracture  healing.  Arch  Orthop  Trauma
Surg 1998;118:126-30. 
10. Ingel BM, Hay SM, Bottjer HM, Eastell R.
Changes in bone mass and bone turnover
following  distal  forearm  fracture.  Osteo-
porosis Int 1999;10:399-407. 
11. Ingel BM, Hay SM, Bottjer HM, Eastell R.
Changes in bone mass and bone turnover
following ankle fracture. Osteoporosis Int
1999;10: 408-15. 
12. Sato Y, Kaji M, Higuchi F, et al. Changes in
bone  and  calcium  metabolism  following
hip  fracture  in  elderly  patients.  Osteo-
porosis Int 2001;12:445-9. 
13. Yu Yahiro JA, Michael RH, Dubin NH, et al.
Serum and urine markers of bone metabo-
lism during the year after hip fracture. J
Am Geriatr Soc 2001;49:877-83.
14. Takahara K, Kamimura M, Nakagawa H,
Uchiyama  S.  Changes  in  biochemical
markers of bone in patients with insuffi-
ciency  fractures.  J  Bone  Miner  Metab
2004;22:618-25. 
15. Akesson K, Kakonen SM, Josefsson PO, et
al.  Fracture  induced  changes  in  bone
turnover: a potential confounder in the use
of biochemical markers in osteoporosis. J
Bone Miner Metab. 2005;23:30-5. 
16. Nakagawa H, Kamimura M, Uchiyama S,
et  al.  Changes  in  total  alkaline  phos-
phatase  (ALP)  level  after  hip  fracture:
comparison  between  femoral  neck  and
trochanter fracture. J Orthop Sci 2006;11:
135-59. 
17. Takahara K, Kamimura M, Hashidate H, et
al. Change of cross-linked telopeptide of
type  I  collagen  (I  CTP)  and  other  bone
resorption markers in patients with bone
fragility  fractures.  J  Orthop  Sci  2007;12:
219-26. 
18. Hannan EL, Magaziner J, Wang JJ, et al.
Mortality and location 6 months after hos-
pitalization  for  hip  fracture:  risk  factors
and  risk-adjusted  hospital  outcomes.
JAMA 2001;285: 2736-42. 
19. Cauley  JA,  Thompson  DE,  Ensrud  KC,
Scott JC, Black D. Risk of mortality follow-
ing  clinical  fractures.  Osteoporosis  Int
2004;11:556-61. 
20. Pedersen  BJ,  Schlemer  A,  Hassager  C,
Christiansen C. Changes in the carboxyl-
terminal propeptide of type I procollagen
and other markers of bone formation upon
five days of bed rest. Bone 1995;17:91-5. 
21. Gregg  EW,  Cauley  JA,  Seeley  DG,  et  al.
Physical activity and osteoporotic fracture
risk in older women. Ann Intern Med 1998;
129:81-8. 
22. Theiler R, Stähelin HB, Kränzlin M, et al.
High  turnover  in  the  elderly.  Arch  Phys
Med Rehabil 1999;80:485-9. 
23. Inoue  M,  Tanaka  H,  Moriwake  T,  et  al.
Altered  biochemical  markers  of  bone
turnover in humans during 120 days of bed
rest. Bone 2000;26:281-6. 
24. Takahashi J, Ebara S, Kamimura M, et al.
Proinflammatory  and  anti-inflammatory
cytokine increases after spinal instrumen-
tation surgery. J Spinal Disord Tech 2002;
15:294-300. 
25. Demura S, Takahashi K, Kawahara N, et
al.  Serum  interleukin-6  response  after
spinal surgery: estimation of surgical mag-
nitude. J Orthop Sci 2006;11:241-7. 
Article